AKI associated with 27% increased risk of hypoglycemia among patients with diabetes.
Diabetes and prediabetes duration also tied to worse subclinical systolic function, diastolic relaxation.
Nadir at BMI of 25 to 30 kg/m stepwise increase to peak for patients with BMI 40 kg/m
Blood Glucose Meter Compatibility with Lancets and Test Strips chart
Antidiabetic agents for the treatment of diabetes including maintenance and max doses chart.
System allows glucose-responsive, closed-loop release to improve therapeutic performance of Ex4.
Relative risk of end-stage renal disease was 0.13 in those diagnosed in 1995-2011 versus 1965-1979.
Over 20% of US veterans were diagnosed with diabetes from 2013 to 2014.
Newly diagnosed T2D patients who strictly maintain glycemic targets may go into remission in 1 year.
Reduced incidence seen with lifestyle changes, meds; however, effect of meds is short-lived.
Delayed-release Niacin may be beneficial to patients with prediabetes and type 2 diabetes.
Saturated fat intake significantly decreases in HbA1c-lowering effect in DPP4i monotherapy in patients with diabetes.
Intensive BP drops may lower cardiovascular risks in both patients with and without diabetes.
In patients with T2DM, taking liraglutide before surgery may be associated with reduced post-op plasma glucose levels.
Atherothrombotic disease risk assessment based upon 10 readily available clinical variables.
Measuring the quality of life and status of health is imperative in patients with diabetes.
The FDA just approved a new short-acting insulin drug, Admelog, for patients with either T1D or T2D.
Remission was linked to 46% patients in intensive weight management programs.
Semaglutide helps patients with diabetes reduce blood glucose levels and lower body weight.
Lifestyle and clinical factors could have been misinterpreted, linking antibiotics to risk of diabetes.
Sulfonylureas and thiazolidinediones adherence was stronger than metformin adherence.
Diabetic patients with chronic kidney disease starting treatment with metformin have a 36% decreased risk of death compared with those starting on a sulfonylurea, study finds.
Severe hypoglycemia is associated with coronary heart disease, cardiovascular mortality, and cancer mortality.
Chemicals that inhibit endocrine functions may be associated with contrasts in diabetes-linked racial and socioeconomic disparities.
The combined effects of high BMI and diabetes resulted in 5.6% of all incident cancers in 2012.
For patients with diabetes, there was a significant decrease in hospitalization rates for acute coronary syndrome, cardiac dysrhythmia, heart failure, and certain strokes.
Effect is larger in chronic heart failure patients with diabetes than CHF patients without diabetes.
But sulfonylureas still most common drugs initiated as second-line treatment.
But significant improvements in HbA1c testing and awareness seen, except in those aged 20 to 44.
Increased risk seen for both all-cause mortality, sudden cardiac death in young people with diabetes.
Renal and Urology News Articles
- CROWNWeb Reporting Gets Up to Speed With Implementation of Dashboard
- Prostate Cancer Gene Testing Guidelines Issued
- Radical Nephrectomy Linked With Worse Kidney Function, Survival
- Acute Kidney Injury Increases Risk for Hypoglycemia in Diabetes Pts
- USPSTF Questions Nontraditional CVD Risk Factors for Assessment
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)